Loading...
Dear readers,
This week, NEJM Journal Watch covered COVID-19 research topics including an antibody “fingerprint,” measuring aerosol generation with intubation and extubation, identification of adult multisystem inflammatory syndrome (MIS-A), improving SARS-CoV-2 detection, phase I studies of two candidate nanoparticle RNA vaccines, MIS-C risk in febrile children, and final results of the ACTT-1 remdesivir trial.
This information appears on the NEJM Journal Watch COVID-19 page (https://www.jwatch.org/covid-19) and on the New England Journal of Medicine coronavirus site (https://www.nejm.org/coronavirus).
As always, we also continue to provide our regular coverage of other important infectious diseases research.